It has been previously
reported that both central and systemic administration of the GABAB
agonist baclofen increases food intake in non-deprived rats (Ebenezer,
1990, Ebenezer et al., 1992). Recent evidence has suggested an
involvement of the mesolimbic dopamine system in the baclofen-induced
hyperphagic response (see Ward et al., 2000). As chronic administration
of amphetamine can alter (i) the firing pattern of neurones within the
mesolimbic system and (ii) GABAB
receptor transmission in the ventral tegmental area (VTA) where mesolimbic
dopamine neurones originate (see Wolf, 2002), the present study was undertaken
to investigate the effects of chronic administration of amphetamine on
baclofen-induced hyperphagia in rats.
The results are
shown in Fig. 1. Rats in the both groups displayed a gradual increase
in food consumption under control conditions (saline) over the 120 min
measurement period. In the Control Group, baclofen produced significant
increases in cumulative food intake at the various measurement intervals
throughout the 120 min, with the greatest increase occurring during the
first 30 min (see Fig. 1A). By contrast, in the Test Group, the effects
of baclofen on food consumption followed a different pattern (see Fig.
1B). Baclofen did not significantly increases cumulative food intake at
30, 60 or 90 min, although the mean cumulative intake was higher than
that of controls. However, at 120 min there was a significant increase
in food intake. The data from this study indicates that chronic treatment
with amphetamine delays the hyperphagic effects of baclofen. Electrophysiological
studies have shown that firing rates of VTA dopamine neurones is increased
for several days after discontinuing repeated administration of amphetamine
(Wolf, 2002). Moreover, GABAB
receptor transmission is enhanced after withdrawal from amphetamine (Wolf,
2002). The present results therefore lend support to the suggestion that
the mesolimbic dopamine system may be involved in the hyperphagic effects
of baclofen. |